Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating the accuracy and precision of the CareSens Air 3 continuous glucose monitoring system in adults with Type 1 Diabetes Mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CareSens Air 3

Snippet

Sponsor: i-SENS, Inc. | Conditions: Type 1 Diabetes Mellitus | NA | Status: RECRUITING